A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation
Clinical trial NCT00723606 · COMPLETED
Trial details
- NCT number
- NCT00723606
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2009-07-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.